Background. Donor supply limits heart transplantation (HT) and relative priority should be
given to cases with greater chances of success. The objectives of this multicenter study were …

Chagas cardiomyopathy (CC) is one of the chronic manifestations of Trypanosoma cruzi (T.
cruzi) infection and is a major public health disease in Latin America. Since it is a chronic …

BACKGROUND: Chagas' disease has been considered a contraindication to heart
transplantation as Trypanosoma cruzi infection could recur after immunosuppression …

Background Heart transplantation (HT) as a therapeutic option for end-stage chronic
Chagas' heart disease (CCHD) is controversial. Reactivation of Trypanosoma cruzi infection …

BACKGROUND: Uncertainties regarding indications for the procedure, proper
immunosuppressive regimen, and the fear of Trypanosoma cruzi infection reactivation are …

A group of Brazilian patients who underwent heart transplants for end-stage Chagas'
disease cardiomyopathy between March, 1986, and June, 1992, were studied. The survival …

Since an initial case in 2006, we noted multiple patients undergoing heart transplantation
(HTx) for Chagas cardiomyopathy (CC) at our transplant program. The clinical …

BACKGROUND: Chagas' disease is the illness caused by the protozoan Trypanosoma cruzi
and it is still endemic in Latin America. Heart transplantation is a therapeutic option for …

Chagas disease (American trypanosomiasis) is caused by the protozoan parasite
Trypanosoma cruzi. Chagas disease following solid-organ transplantation has occurred in …

This review addresses relevant aspects of Chagas disease in the solid organ transplantation
setting. This trypanosomiasis was geographically restricted to America, but migration has …